---
title: Dr Chandramouli Nagarajan
permalink: /smsg-members/chandramouli-nagarajan/
variant: tiptap
description: ""
---
<p></p>
<div class="isomer-image-wrapper">
<img style="width: 30%;" height="auto" width="100%" alt="" src="/images/Singapore Myeloma Study Group/Member Photos/Chandramouli_Nagarajan.png">
</div>
<h4><strong>Profile</strong></h4>
<p>Dr. Chandramouli is a Senior Consultant Hematologist and Transplant Physician
in the Department of Hematology at Singapore General Hospital (SGH) and
National Cancer Center Singapore (NCCS).</p>
<p>After completing undergraduate and post graduate education from India
and the United Kingdom, he subspecialized in Hematology before moving to
Singapore. He serves as the Director / Sub-Specialty Lead for Multiple
Myeloma and Lymphoma in SGH and SingHealth-Duke NUS Blood Cancer Center.
He has a passion for conducting clinical trials especially using novel
therapies. As a Principal Investigator under the auspices of the International
Myeloma Foundation and via active collaborations with Industry partners,
he aspires to bring newer novel therapies to patients in Southeast Asia,
through clinically meaningful and patient focused investigator-initiated
and sponsored studies.</p>
<p>He is a member of the Asian Myeloma Network, International Myeloma Working
Group, International Myeloma Society and European Research Initiative on
CLL as well as leading many advisory boards and global clinical trial steering
committees. His awards include the Clinical trials research training in
Hematology (CRTH) fellowship award from European Hematology Association,
Team Health care manpower development programme (HMDP) award for Lymphoma
/ Myeloma Cell therapy at the Helen Diller Comprehensive Cancer Center,
University of California San Francisco.</p>
<p>His other area of interest is medical education. He is an RCP accredited
Educator and has served as the Programme Director for SingHealth Hematology
Senior Residency Programme from 2018 – Jun 2023.</p>
<h4><strong>Affiliations</strong></h4>
<ul data-tight="true" class="tight">
<li>
<p>Senior Consultant, Dept. of&nbsp;Hematology. Singapore General Hospital
(SGH)</p>
</li>
<li>
<p>Senior Consultant, National Cancer Centre&nbsp;Singapore​</p>
</li>
<li>
<p>Director Myeloma Services and Lymphoproliferative disorders, SingHealth
Duke-NUS Blood Cancer Center (SDBCC)</p>
</li>
<li>
<p>Clinical Assistant Professor, Duke-NUS Medical School</p>
</li>
<li>
<p>Clinical Senior Lecturer, Yong Loo Lin School Of Medicine</p>
</li>
<li>
<p>Campus Chief, SGH, SingHealth Duke NUS Cell Therapy Center</p>
</li>
<li>
<p>Director of Education, SingHealth Duke-NUS Blood Cancer Center (SDBCC)</p>
</li>
<li>
<p>Implementation office, Advanced Cell Therapy and Research Institute Singapore
(ACTRIS)</p>
</li>
</ul>
<p>&nbsp;</p>